Acceleron Pharma Inc. Debt to Equity Ratio 2013-2021 | XLRN
Current and historical debt to equity ratio values for Acceleron Pharma Inc. (XLRN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Acceleron Pharma Inc. debt/equity for the three months ending September 30, 2021 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2021-09-30 |
$0.07B |
$0.72B |
0.10 |
2021-06-30 |
$0.07B |
$0.76B |
0.10 |
2021-03-31 |
$0.07B |
$0.81B |
0.08 |
2020-12-31 |
$0.08B |
$0.86B |
0.09 |
2020-09-30 |
$0.05B |
$0.90B |
0.06 |
2020-06-30 |
$0.06B |
$0.42B |
0.14 |
2020-03-31 |
$0.05B |
$0.41B |
0.12 |
2019-12-31 |
$0.06B |
$0.45B |
0.12 |
2019-09-30 |
$0.06B |
$0.47B |
0.12 |
2019-06-30 |
$0.05B |
$0.50B |
0.10 |
2019-03-31 |
$0.05B |
$0.51B |
0.10 |
2018-12-31 |
$0.02B |
$0.29B |
0.08 |
2018-09-30 |
$0.02B |
$0.32B |
0.06 |
2018-06-30 |
$0.02B |
$0.33B |
0.06 |
2018-03-31 |
$0.02B |
$0.35B |
0.05 |
2017-12-31 |
$0.02B |
$0.37B |
0.07 |
2017-09-30 |
$0.02B |
$0.36B |
0.06 |
2017-06-30 |
$0.02B |
$0.19B |
0.11 |
2017-03-31 |
$0.02B |
$0.21B |
0.10 |
2016-12-31 |
$0.02B |
$0.23B |
0.10 |
2016-09-30 |
$0.03B |
$0.23B |
0.15 |
2016-06-30 |
$0.03B |
$0.24B |
0.13 |
2016-03-31 |
$0.03B |
$0.26B |
0.11 |
2015-12-31 |
$0.04B |
$0.11B |
0.34 |
2015-09-30 |
$0.03B |
$0.13B |
0.20 |
2015-06-30 |
$0.03B |
$0.14B |
0.20 |
2015-03-31 |
$0.03B |
$0.15B |
0.20 |
2014-12-31 |
$0.03B |
$0.16B |
0.19 |
2014-09-30 |
$0.03B |
$0.17B |
0.20 |
2014-06-30 |
$0.05B |
$0.17B |
0.26 |
2014-03-31 |
$0.04B |
$0.18B |
0.24 |
2013-12-31 |
$0.07B |
$0.06B |
1.14 |
2013-09-30 |
$0.05B |
$0.08B |
0.71 |
2013-06-30 |
$0.00B |
|
0.00 |
2013-03-31 |
$0.00B |
|
0.00 |
2012-09-30 |
$0.00B |
|
0.00 |